Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer

Cuzick, J, Yang, Z H, Fisher, G, Tikishvili, E, Stone, S, Lanchbury, J S, Camacho, N, Merson, S, Brewer, D ORCID: https://orcid.org/0000-0003-4753-9794, Cooper, C S ORCID: https://orcid.org/0000-0003-2013-8042, Clark, J, Berney, D M, Møller, H, Scardino, P and Sangale, Z and Transatlantic Prostate Group (2013) Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer. British Journal of Cancer, 108 (12). pp. 2582-2589. ISSN 0007-0920

Full text not available from this repository. (Request a copy)

Abstract

The natural history of prostate cancer is highly variable and difficult to predict. We report on the prognostic value of phosphatase and tensin homologue (PTEN) loss in a cohort of 675 men with conservatively managed prostate cancer diagnosed by transurethral resection of the prostate.

Item Type:	Article
Uncontrolled Keywords:	adenocarcinoma,adult,aged,gene expression regulation, neoplastic,gene silencing,humans,immunohistochemistry,in situ hybridization, fluorescence,ki-67 antigen,male,middle aged,neoplasm grading,pten phosphohydrolase,predictive value of tests,prognosis,prostate-specific antigen,prostatic neoplasms,transurethral resection of prostate,tumor markers, biological,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School:	Faculty of Science > School of Biological Sciences Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Cancer Studies Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health
Depositing User:	Pure Connector
Date Deposited:	06 Jan 2014 14:16
Last Modified:	19 Oct 2023 01:15
URI:	https://ueaeprints.uea.ac.uk/id/eprint/47020
DOI:	10.1038/bjc.2013.248

Actions (login required)

View Item